$343 Million is the total value of MWG Management Ltd.'s 2 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BEAM | Sell | Beam Therapeutics Inc. | $187,027,000 | -9.0% | 2,346,934 | -0.7% | 54.51% | +118.7% |
| LYEL | Sell | LYELL IMMUNOPHARMA INC | $156,056,000 | -48.1% | 20,162,332 | -0.7% | 45.49% | +24.9% |
| ILMN | Exit | Illumina Inc | $0 | – | -337,102 | -100.0% | -16.58% | – |
| RELX | Exit | RELX PLCsponsored adr | $0 | – | -40,254,832 | -100.0% | -22.06% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Milky Way Investments Limited #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEAM THERAPEUTICS INC | 12 | Q3 2023 | 94.5% |
| LYELL IMMUNOPHARMA INC | 10 | Q3 2023 | 59.1% |
| PRIME MEDICINE INC | 4 | Q3 2023 | 17.4% |
| VIR BIOTECHNOLOGY INC | 3 | Q2 2021 | 8.1% |
| RELX PLC | 2 | Q3 2021 | 37.3% |
| Illumina Inc | 1 | Q3 2021 | 16.6% |
View MWG Management Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| SC 13G | 2022-02-14 |
View MWG Management Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.